The country's health minister, Anvisa confirmed the person died following the trial of the drug. The health authority said the investigation will be held on the matter. Despite the death of the person, the health authority confirmed trials will continue.
"The drug is currently undergoing phase three clinical trials in the country. Brazil has a plan in place to purchase the drug and produce it as its biomedical research center if it clears the final phase of trials."
Despite the death of the volunteer, oxford university has stated there are no concerns surrounding the safety of the trials.
The vaccine is seen as one of the leading drugs, with the UK government signing a deal for 100millin doses.
Both Indian and south Africa have resumed clinical trials of the potential vaccine.
AstraZeneca has also signed an agreement with the Europes inclusive vaccine alliance.
"And we now need to see whether or not immune responses that we see translate into protection,"
This comes as 26,688 people tested positive for the virus in the UK across all settings - the total now stands at 789,229.
There were also 191 deaths reported today.
Comments
Post a Comment